Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 362 entries
Sorted by: Best Match Show Resources per page
Harnessing extracellular vesicles to direct endochondral repair of large bone defects.

Bone & joint research

Ferreira E, Porter RM.
PMID: 29922444
Bone Joint Res. 2018 May 05;7(4):263-273. doi: 10.1302/2046-3758.74.BJR-2018-0006. eCollection 2018 Apr.

Large bone defects remain a tremendous clinical challenge. There is growing evidence in support of treatment strategies that direct defect repair through an endochondral route, involving a cartilage intermediate. While culture-expanded stem/progenitor cells are being evaluated for this purpose,...

Cite
Ferreira E, Porter RM. Harnessing extracellular vesicles to direct endochondral repair of large bone defects. Bone Joint Res. 2018;7(4):263-273doi: 10.1302/2046-3758.74.BJR-2018-0006.
Ferreira, E., & Porter, R. M. (2018). Harnessing extracellular vesicles to direct endochondral repair of large bone defects. Bone & joint research, 7(4), 263-273. https://doi.org/10.1302/2046-3758.74.BJR-2018-0006
Ferreira, E, and Porter, R M. "Harnessing extracellular vesicles to direct endochondral repair of large bone defects." Bone & joint research vol. 7,4 (2018): 263-273. doi: https://doi.org/10.1302/2046-3758.74.BJR-2018-0006
Ferreira E, Porter RM. Harnessing extracellular vesicles to direct endochondral repair of large bone defects. Bone Joint Res. 2018 May 05;7(4):263-273. doi: 10.1302/2046-3758.74.BJR-2018-0006. eCollection 2018 Apr. PMID: 29922444; PMCID: PMC5987693.
Copy Download .nbib Format: NLM
Whey Protein Isolate-Supplemented Beverage, Fermented by .

Frontiers in microbiology

Cordeiro BF, Oliveira ER, da Silva SH, Savassi BM, Acurcio LB, Lemos L, Alves JL, Carvalho Assis H, Vieira AT, Faria AMC, Ferreira E, Le Loir Y, Jan G, Goulart LR, Azevedo V, Carvalho RDO, do Carmo FLR.
PMID: 30258413
Front Microbiol. 2018 Sep 12;9:2035. doi: 10.3389/fmicb.2018.02035. eCollection 2018.

Mucositis is a clinically important gastrointestinal inflammatory infirmity, generated by antineoplastic drugs cytotoxic effects. The inflammatory process caused by this disease frequently leads to derangements in the alimentary tract and great malaise for the patient. Novel strategies are necessary...

Cite
Cordeiro BF, Oliveira ER, da Silva SH, et al. Whey Protein Isolate-Supplemented Beverage, Fermented by . Front Microbiol. 2018;9:2035doi: 10.3389/fmicb.2018.02035.
Cordeiro, B. F., Oliveira, E. R., da Silva, S. H., Savassi, B. M., Acurcio, L. B., Lemos, L., Alves, J. L., Carvalho Assis, H., Vieira, A. T., Faria, A. M. C., Ferreira, E., Le Loir, Y., Jan, G., Goulart, L. R., Azevedo, V., Carvalho, R. D. O., & do Carmo, F. L. R. (2018). Whey Protein Isolate-Supplemented Beverage, Fermented by . Frontiers in microbiology, 92035. https://doi.org/10.3389/fmicb.2018.02035
Cordeiro, Bárbara F, et al. "Whey Protein Isolate-Supplemented Beverage, Fermented by ." Frontiers in microbiology vol. 9 (2018): 2035. doi: https://doi.org/10.3389/fmicb.2018.02035
Cordeiro BF, Oliveira ER, da Silva SH, Savassi BM, Acurcio LB, Lemos L, Alves JL, Carvalho Assis H, Vieira AT, Faria AMC, Ferreira E, Le Loir Y, Jan G, Goulart LR, Azevedo V, Carvalho RDO, do Carmo FLR. Whey Protein Isolate-Supplemented Beverage, Fermented by . Front Microbiol. 2018 Sep 12;9:2035. doi: 10.3389/fmicb.2018.02035. eCollection 2018. PMID: 30258413; PMCID: PMC6143704.
Copy Download .nbib Format: NLM
Assessing the antibiotic susceptibility of freshwater Cyanobacteria spp.

Frontiers in microbiology

Dias E, Oliveira M, Jones-Dias D, Vasconcelos V, Ferreira E, Manageiro V, Caniça M.
PMID: 26322027
Front Microbiol. 2015 Aug 11;6:799. doi: 10.3389/fmicb.2015.00799. eCollection 2015.

Freshwater is a vehicle for the emergence and dissemination of antibiotic resistance. Cyanobacteria are ubiquitous in freshwater, where they are exposed to antibiotics and resistant organisms, but their role on water resistome was never evaluated. Data concerning the effects...

Cite
Dias E, Oliveira M, Jones-Dias D, et al. Assessing the antibiotic susceptibility of freshwater Cyanobacteria spp. Front Microbiol. 2015;6:799doi: 10.3389/fmicb.2015.00799.
Dias, E., Oliveira, M., Jones-Dias, D., Vasconcelos, V., Ferreira, E., Manageiro, V., & Caniça, M. (2015). Assessing the antibiotic susceptibility of freshwater Cyanobacteria spp. Frontiers in microbiology, 6799. https://doi.org/10.3389/fmicb.2015.00799
Dias, Elsa, et al. "Assessing the antibiotic susceptibility of freshwater Cyanobacteria spp." Frontiers in microbiology vol. 6 (2015): 799. doi: https://doi.org/10.3389/fmicb.2015.00799
Dias E, Oliveira M, Jones-Dias D, Vasconcelos V, Ferreira E, Manageiro V, Caniça M. Assessing the antibiotic susceptibility of freshwater Cyanobacteria spp. Front Microbiol. 2015 Aug 11;6:799. doi: 10.3389/fmicb.2015.00799. eCollection 2015. PMID: 26322027; PMCID: PMC4531292.
Copy Download .nbib Format: NLM
Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function.

Canadian journal of kidney health and disease

Levin A, Adams E, Barrett BJ, Beanlands H, Burns KD, Chiu HH, Chong K, Dart A, Ferera J, Fernandez N, Fowler E, Garg AX, Gilbert R, Harris H, Harvey R, Hemmelgarn B, James M, Johnson J, Kappel J, Komenda P, McCormick M, McIntyre C, Mahmud F, Pei Y, Pollock G, Reich H, Rosenblum ND, Scholey J, Sochett E, Tang M, Tangri N, Tonelli M, Turner C, Walsh M, Woods C, Manns B.
PMID: 29372064
Can J Kidney Health Dis. 2018 Jan 17;5:2054358117749530. doi: 10.1177/2054358117749530. eCollection 2018.

PURPOSE OF REVIEW: This article serves to describe the Can-SOLVE CKD network, a program of research projects and infrastructure that has excited patients and given them hope that we can truly transform the care they receive.ISSUE: Chronic kidney disease...

Cite
Levin A, Adams E, Barrett BJ, et al. Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function. Can J Kidney Health Dis. 2018;5:2054358117749530doi: 10.1177/2054358117749530.
Levin, A., Adams, E., Barrett, B. J., Beanlands, H., Burns, K. D., Chiu, H. H., Chong, K., Dart, A., Ferera, J., Fernandez, N., Fowler, E., Garg, A. X., Gilbert, R., Harris, H., Harvey, R., Hemmelgarn, B., James, M., Johnson, J., Kappel, J., Komenda, P., McCormick, M., McIntyre, C., Mahmud, F., Pei, Y., Pollock, G., Reich, H., Rosenblum, N. D., Scholey, J., Sochett, E., Tang, M., Tangri, N., Tonelli, M., Turner, C., Walsh, M., Woods, C., & Manns, B. (2018). Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function. Canadian journal of kidney health and disease, 52054358117749530. https://doi.org/10.1177/2054358117749530
Levin, Adeera, et al. "Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function." Canadian journal of kidney health and disease vol. 5 (2018): 2054358117749530. doi: https://doi.org/10.1177/2054358117749530
Levin A, Adams E, Barrett BJ, Beanlands H, Burns KD, Chiu HH, Chong K, Dart A, Ferera J, Fernandez N, Fowler E, Garg AX, Gilbert R, Harris H, Harvey R, Hemmelgarn B, James M, Johnson J, Kappel J, Komenda P, McCormick M, McIntyre C, Mahmud F, Pei Y, Pollock G, Reich H, Rosenblum ND, Scholey J, Sochett E, Tang M, Tangri N, Tonelli M, Turner C, Walsh M, Woods C, Manns B. Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function. Can J Kidney Health Dis. 2018 Jan 17;5:2054358117749530. doi: 10.1177/2054358117749530. eCollection 2018. PMID: 29372064; PMCID: PMC5774731.
Copy Download .nbib Format: NLM
Plasmid-Mediated Colistin Resistance (.

Microorganisms

Manageiro V, Jones-Dias D, Ferreira E, Caniça M.
PMID: 32197505
Microorganisms. 2020 Mar 18;8(3). doi: 10.3390/microorganisms8030429.

In this study, we report the presence of the plasmid-mediated colistin resistance (PMCR)-encoding gene

Cite
Manageiro V, Jones-Dias D, Ferreira E, et al. Plasmid-Mediated Colistin Resistance (. Microorganisms. 2020;8(3)doi: 10.3390/microorganisms8030429.
Manageiro, V., Jones-Dias, D., Ferreira, E., & Caniça, M. (2020). Plasmid-Mediated Colistin Resistance (. Microorganisms, 8(3), . https://doi.org/10.3390/microorganisms8030429
Manageiro, Vera, et al. "Plasmid-Mediated Colistin Resistance (." Microorganisms vol. 8,3 (2020). doi: https://doi.org/10.3390/microorganisms8030429
Manageiro V, Jones-Dias D, Ferreira E, Caniça M. Plasmid-Mediated Colistin Resistance (. Microorganisms. 2020 Mar 18;8(3). doi: 10.3390/microorganisms8030429. PMID: 32197505; PMCID: PMC7143947.
Copy Download .nbib Format: NLM
Bifidobacterium longum subsp. longum 5.

Life sciences

Quintanilha MF, Miranda VC, Souza RO, Gallotti B, Cruz C, Santos EA, Alvarez-Leite JI, Jesus LCL, Azevedo V, Trindade LM, Cardoso VN, Ferreira E, Carvalho BA, Soares PMG, Vieira AT, Nicoli JR, Martins FS.
PMID: 34922941
Life Sci. 2022 Jan 15;289:120243. doi: 10.1016/j.lfs.2021.120243. Epub 2021 Dec 16.

Intestinal mucositis (IM) is a critical side-effect associated with antineoplastic therapy. Treatment available is only palliative and often not effective. However, alternative therapeutic strategies, such as probiotics, have attracted significant attention due to their immune-modulatory action in several diseases....

Cite
Quintanilha MF, Miranda VC, Souza RO, et al. Bifidobacterium longum subsp. longum 5. Life Sci. 2021;289:120243doi: 10.1016/j.lfs.2021.120243.
Quintanilha, M. F., Miranda, V. C., Souza, R. O., Gallotti, B., Cruz, C., Santos, E. A., Alvarez-Leite, J. I., Jesus, L. C. L., Azevedo, V., Trindade, L. M., Cardoso, V. N., Ferreira, E., Carvalho, B. A., Soares, P. M. G., Vieira, A. T., Nicoli, J. R., & Martins, F. S. (2022). Bifidobacterium longum subsp. longum 5. Life sciences, 289120243. https://doi.org/10.1016/j.lfs.2021.120243
Quintanilha, Mônica F, et al. "Bifidobacterium longum subsp. longum 5." Life sciences vol. 289 (2022): 120243. doi: https://doi.org/10.1016/j.lfs.2021.120243
Quintanilha MF, Miranda VC, Souza RO, Gallotti B, Cruz C, Santos EA, Alvarez-Leite JI, Jesus LCL, Azevedo V, Trindade LM, Cardoso VN, Ferreira E, Carvalho BA, Soares PMG, Vieira AT, Nicoli JR, Martins FS. Bifidobacterium longum subsp. longum 5. Life Sci. 2022 Jan 15;289:120243. doi: 10.1016/j.lfs.2021.120243. Epub 2021 Dec 16. PMID: 34922941.
Copy Download .nbib Format: NLM
Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption.

International journal of molecular sciences

Ferreira E, Almeida ZL, Cruz PF, Silva E Sousa M, Veríssimo P, Brito RMM.
PMID: 35008816
Int J Mol Sci. 2021 Dec 30;23(1). doi: 10.3390/ijms23010391.

Several degenerative amyloid diseases, with no fully effective treatment, affect millions of people worldwide. These pathologies-amyloidoses-are known to be associated with the formation of ordered protein aggregates and highly stable and insoluble amyloid fibrils, which are deposited in multiple...

Cite
Ferreira E, Almeida ZL, Cruz PF, et al. Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010391.
Ferreira, E., Almeida, Z. L., Cruz, P. F., Silva E Sousa, M., Veríssimo, P., & Brito, R. M. M. (2021). Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010391
Ferreira, Elisabete, et al. "Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010391
Ferreira E, Almeida ZL, Cruz PF, Silva E Sousa M, Veríssimo P, Brito RMM. Searching for the Best Transthyretin Aggregation Protocol to Study Amyloid Fibril Disruption. Int J Mol Sci. 2021 Dec 30;23(1). doi: 10.3390/ijms23010391. PMID: 35008816; PMCID: PMC8745744.
Copy Download .nbib Format: NLM
Comparison of Surface Properties of Sepiolite and Palygorskite: Surface Energy and Nanoroughness.

Nanomaterials (Basel, Switzerland)

Almeida R, Ferraz E, Santarén J, Gamelas JAF.
PMID: 34208459
Nanomaterials (Basel). 2021 Jun 16;11(6). doi: 10.3390/nano11061579.

The surface properties of two sepiolite samples and one palygorskite sample were compared using inverse gas chromatography (IGC). Samples were previously conditioned at appropriate temperatures for the removal of all zeolitic water. Dispersive (or Lifshitz-van der Waals) component of...

Cite
Almeida R, Ferraz E, Santarén J, et al. Comparison of Surface Properties of Sepiolite and Palygorskite: Surface Energy and Nanoroughness. Nanomaterials (Basel). 2021;11(6)doi: 10.3390/nano11061579.
Almeida, R., Ferraz, E., Santarén, J., & Gamelas, J. A. F. (2021). Comparison of Surface Properties of Sepiolite and Palygorskite: Surface Energy and Nanoroughness. Nanomaterials (Basel, Switzerland), 11(6), . https://doi.org/10.3390/nano11061579
Almeida, Ricardo, et al. "Comparison of Surface Properties of Sepiolite and Palygorskite: Surface Energy and Nanoroughness." Nanomaterials (Basel, Switzerland) vol. 11,6 (2021). doi: https://doi.org/10.3390/nano11061579
Almeida R, Ferraz E, Santarén J, Gamelas JAF. Comparison of Surface Properties of Sepiolite and Palygorskite: Surface Energy and Nanoroughness. Nanomaterials (Basel). 2021 Jun 16;11(6). doi: 10.3390/nano11061579. PMID: 34208459; PMCID: PMC8235428.
Copy Download .nbib Format: NLM
SlpB Protein Enhances the Probiotic Potential of .

Frontiers in pharmacology

Belo GA, Cordeiro BF, Oliveira ER, Braga MP, da Silva SH, Costa BG, Martins FDS, Jan G, Le Loir Y, Gala-García A, Ferreira E, Azevedo V, do Carmo FLR.
PMID: 34987390
Front Pharmacol. 2021 Dec 20;12:755825. doi: 10.3389/fphar.2021.755825. eCollection 2021.

Bacteria used in the production of fermented food products have been investigated for their potential role as modulators of inflammation in gastrointestinal tract disorders such as inflammatory bowel diseases (IBD) that cause irreversible changes in the structure and function...

Cite
Belo GA, Cordeiro BF, Oliveira ER, et al. SlpB Protein Enhances the Probiotic Potential of . Front Pharmacol. 2021;12:755825doi: 10.3389/fphar.2021.755825.
Belo, G. A., Cordeiro, B. F., Oliveira, E. R., Braga, M. P., da Silva, S. H., Costa, B. G., Martins, F. D. S., Jan, G., Le Loir, Y., Gala-García, A., Ferreira, E., Azevedo, V., & do Carmo, F. L. R. (2021). SlpB Protein Enhances the Probiotic Potential of . Frontiers in pharmacology, 12755825. https://doi.org/10.3389/fphar.2021.755825
Belo, Giovanna A, et al. "SlpB Protein Enhances the Probiotic Potential of ." Frontiers in pharmacology vol. 12 (2021): 755825. doi: https://doi.org/10.3389/fphar.2021.755825
Belo GA, Cordeiro BF, Oliveira ER, Braga MP, da Silva SH, Costa BG, Martins FDS, Jan G, Le Loir Y, Gala-García A, Ferreira E, Azevedo V, do Carmo FLR. SlpB Protein Enhances the Probiotic Potential of . Front Pharmacol. 2021 Dec 20;12:755825. doi: 10.3389/fphar.2021.755825. eCollection 2021. PMID: 34987390; PMCID: PMC8721164.
Copy Download .nbib Format: NLM
Dietary Exposure to Mycotoxins through Alcoholic and Non-Alcoholic Beverages in Valencia, Spain.

Toxins

Carballo D, Fernández-Franzón M, Ferrer E, Pallarés N, Berrada H.
PMID: 34202720
Toxins (Basel). 2021 Jun 24;13(7). doi: 10.3390/toxins13070438.

The present study investigated the presence of 30 mycotoxins in 110 beverage samples of beer, wine, cava, and cider purchased in Valencia (Spain). A validated method based on dispersive liquid-liquid microextraction and chromatographic methods coupled with tandem mass spectrometry...

Cite
Carballo D, Fernández-Franzón M, Ferrer E, et al. Dietary Exposure to Mycotoxins through Alcoholic and Non-Alcoholic Beverages in Valencia, Spain. Toxins (Basel). 2021;13(7)doi: 10.3390/toxins13070438.
Carballo, D., Fernández-Franzón, M., Ferrer, E., Pallarés, N., & Berrada, H. (2021). Dietary Exposure to Mycotoxins through Alcoholic and Non-Alcoholic Beverages in Valencia, Spain. Toxins, 13(7), . https://doi.org/10.3390/toxins13070438
Carballo, Dionisia, et al. "Dietary Exposure to Mycotoxins through Alcoholic and Non-Alcoholic Beverages in Valencia, Spain." Toxins vol. 13,7 (2021). doi: https://doi.org/10.3390/toxins13070438
Carballo D, Fernández-Franzón M, Ferrer E, Pallarés N, Berrada H. Dietary Exposure to Mycotoxins through Alcoholic and Non-Alcoholic Beverages in Valencia, Spain. Toxins (Basel). 2021 Jun 24;13(7). doi: 10.3390/toxins13070438. PMID: 34202720; PMCID: PMC8309788.
Copy Download .nbib Format: NLM
Dynamic Mixture Modeling with .

Multivariate behavioral research

Liu S, Ou L, Ferrer E.
PMID: 32856484
Multivariate Behav Res. 2021 Nov-Dec;56(6):941-955. doi: 10.1080/00273171.2020.1794775. Epub 2020 Aug 28.

Mixture modeling is commonly used to model sample heterogeneity by identifying unobserved classes of individuals with similar characteristics. Despite abundance of evidence in the literature suggesting that individuals are often characterized by different dynamic processes underlying their physiological, cognitive,...

Cite
Liu S, Ou L, Ferrer E. Dynamic Mixture Modeling with . Multivariate Behav Res. 2020;56(6):941-955doi: 10.1080/00273171.2020.1794775.
Liu, S., Ou, L., & Ferrer, E. (2021). Dynamic Mixture Modeling with . Multivariate behavioral research, 56(6), 941-955. https://doi.org/10.1080/00273171.2020.1794775
Liu, Siwei, et al. "Dynamic Mixture Modeling with ." Multivariate behavioral research vol. 56,6 (2021): 941-955. doi: https://doi.org/10.1080/00273171.2020.1794775
Liu S, Ou L, Ferrer E. Dynamic Mixture Modeling with . Multivariate Behav Res. 2021 Nov-Dec;56(6):941-955. doi: 10.1080/00273171.2020.1794775. Epub 2020 Aug 28. PMID: 32856484.
Copy Download .nbib Format: NLM
Peripheral microvascular dysfunction is also present in patients with ischemia and no obstructive coronary artery disease (INOCA).

Clinical hemorheology and microcirculation

Junqueira CLC, Ferreira E, Junqueira ASM, Cyrino FZGA, Maranhão PA, Kraemer-Aguiar LG, Bottino DA, de Souza MDGC, Bouskela E.
PMID: 34151847
Clin Hemorheol Microcirc. 2021;79(3):381-393. doi: 10.3233/CH-201065.

BACKGROUND: In patients with ischemia and no obstructive coronary artery disease (INOCA), coronary microvascular dysfunction is associated with higher rate of major adverse cardiovascular events.OBJECTIVE: To demonstrate if microvascular dysfunction present in coronary microcirculation of patients with INOCA may...

Cite
Junqueira CLC, Ferreira E, Junqueira ASM, et al. Peripheral microvascular dysfunction is also present in patients with ischemia and no obstructive coronary artery disease (INOCA). Clin Hemorheol Microcirc. 2021;79(3):381-393doi: 10.3233/CH-201065.
Junqueira, C. L. C., Ferreira, E., Junqueira, A. S. M., Cyrino, F. Z. G. A., Maranhão, P. A., Kraemer-Aguiar, L. G., Bottino, D. A., de Souza, M. D. G. C., & Bouskela, E. (2021). Peripheral microvascular dysfunction is also present in patients with ischemia and no obstructive coronary artery disease (INOCA). Clinical hemorheology and microcirculation, 79(3), 381-393. https://doi.org/10.3233/CH-201065
Junqueira, Camillo L C, et al. "Peripheral microvascular dysfunction is also present in patients with ischemia and no obstructive coronary artery disease (INOCA)." Clinical hemorheology and microcirculation vol. 79,3 (2021): 381-393. doi: https://doi.org/10.3233/CH-201065
Junqueira CLC, Ferreira E, Junqueira ASM, Cyrino FZGA, Maranhão PA, Kraemer-Aguiar LG, Bottino DA, de Souza MDGC, Bouskela E. Peripheral microvascular dysfunction is also present in patients with ischemia and no obstructive coronary artery disease (INOCA). Clin Hemorheol Microcirc. 2021;79(3):381-393. doi: 10.3233/CH-201065. PMID: 34151847.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 362 entries